"All-in-One Assay", a direct phenotypic anti-human immunodeficiency virus type 1 drug resistance assay for three-drug combination therapies that takes into consideration in vivo drug concentrations.

doi:10.1016/s0166-0934(03)00150-2

Article

"All-in-One Assay", a direct phenotypic anti-human immunodeficiency virus type 1 drug resistance assay for three-drug combination therapies that takes into consideration in vivo drug concentrations.

Journal of virological methods - 1 Jul 2003

Hachiya Atsuko, Matsuoka-Aizawa Saori, Tsuchiya Kiyoto, Gatanaga Hiroyuki, Kimura Satoshi, Tatsumi Masashi, Oka Shinichi

Abstract excerpt

A novel phenotypic anti-human immunodeficiency virus type 1 (HIV-1) drug resistance assay is described. Three drugs at concentrations equivalent to those determined in in vivo pharmacokinetics, were mixed in a well, serially diluted by 10-folds, and added to incubations of clinical HIV-1 isolates and CCR-5 expressing HeLa/CD4+ cells which was previously reported as the MAGIC-5 cells (Antimicrob. Agents Chemother....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

"All-in-One Assay", a direct phenotypic anti-human immunodeficiency virus type 1 drug resistance assay for three-drug combination therapies that takes into consideration in vivo drug concentrations.

Abstract excerpt

Topics

Related research